Despite the fact that several survival pathways are activated in tumor cells post-PDT [42], we decided to explore those related to HIF-1 modulation [43], such as PI3K-Akt and MEK1/2-ERK1/2. The gene discussed is MAP2K1; the disease is neoplasm.